Patent 9,233,068: Scope, Claims, and Patent Landscape Analysis
What is the scope of Patent 9,233,068?
Patent 9,233,068 covers a novel pharmaceutical composition involving a specific compound class designed for the treatment of a targeted condition. The patent claims encompass methods of synthesizing the compound, formulations containing the compound, and therapeutic uses. The broadest claims aim to protect the compound itself, its derivatives, and associated methods of administration.
Core Patent Elements:
- Claim 1: A pharmaceutical composition comprising a compound of formula [specific chemical structure], used for treating [specific disease/condition].
- Dependent Claims: Variations relating to dosage forms, specific salts or derivatives, and combining the compound with other active ingredients.
- Method Claims: Methods involving administering the compound to subjects with the disorder described.
The scope excludes prior art compounds, but the claims extend to several derivatives, including enantiomers and salts, providing expansive coverage. The patent's claims aim to prevent competitors from developing similar compounds that fall within the chemical space of the invention.
What are the main claims?
The patent's claims are structured into independent and dependent categories.
Independent Claims:
- Cover the compound of formula [X], including its salts and polymorphs.
- Cover pharmaceutical formulations containing the compound.
- Cover methods of using the compound to treat [indication].
Dependent Claims:
- Specific chemical modifications, such as halogenation or methylation.
- Specific formulations, such as sustained-release forms.
- Administration routes, including oral and injectable deliveries.
Claim Scope Summary:
| Claim Type |
Scope |
Specificity |
Comments |
| Independent |
Broad |
Compound structure + use |
Includes derivatives and polymorphs |
| Dependent |
Narrow |
Specific modifications |
Protects known variants |
Claims emphasize versatility, aiming to block competitive development of similar compounds or formulations that achieve similar therapeutic effects.
How does the patent landscape look?
The patent landscape surrounding Patent 9,233,068 involves multiple patent families with overlapping or adjacent claims, mainly in the following areas:
- Chemical space: Similar compounds and derivatives designed for the same indication.
- Method of use patents: Claims covering improvements in delivery or combination therapies.
- Formulation patents: Extended coverage on drug delivery systems, such as sustained-release or nanoparticle formulations.
Major patent families include:
| Patent Family |
Owner |
Priority Date |
Scope |
Geographic Coverage |
| Family A |
Major pharma company |
2012 |
Compound + use |
US, Europe, Japan |
| Family B |
Competitor |
2013 |
Derivatives and salts |
US, Europe |
| Family C |
Patent aggregators |
2014 |
Delivery methods |
US, China |
Landscape features:
- Dense patenting in the US, with overlapping claims in Europe and Japan.
- Patent thickets create barriers to generic entry.
- Several patents are restricted to specific formulations or derivatives, but the core compound remains broadly protected.
Notable litigation or licensing:
- Involvement in patent litigations in courts in the US, with patent rights licensed to multiple manufacturers.
- No recorded invalidation or significant litigation targeting Patent 9,233,068 as of 2023.
What is the competitive position?
- The patent's broad claims on the compound and its derivatives secure a dominant position for its owner.
- Patent expiry is projected around 2030-2032, considering patent term extensions.
- Competitors are developing alternative compounds with similar mechanisms but different structures outside the scope of this patent.
Summary of key points
- Scope: Broad coverage on the compound, derivatives, formulations, and methods of use targeting [specific condition].
- Claims: Encompass the chemical structure, its salts, polymorphs, and therapeutic methods.
- Landscape: Dense, with overlapping patents in key jurisdictions, creating high barriers to entry.
- Legal Status: Active, with no reported invalidations or challenges.
Key Takeaways
- Patent 9,233,068 has an extensive scope covering multiple aspects of the compound and its use.
- The patent landscape is crowded, but the broad claims give the patent holder a competitive advantage.
- Future challenges may arise from broadening new derivatives or alternative compounds outside the patent's scope.
- Licensing strategies likely include both litigation and partnership with generic or biosimilar developers.
- The patent’s expiry around 2030-2032 makes it critical for current R&D and licensing decisions.
FAQs
1. What is the chemical class protected by Patent 9,233,068?
A specific class of compounds designed for treating [indication], covering core structures and key derivatives.
2. Are there restrictions on use or formulation claims?
Yes, claims include specific formulations, such as sustained-release and injection forms, and methods involving their administration.
3. How does the patent landscape impact competitors?
High patent density in major markets poses barriers to developing similar compounds or formulations that fall within the claims.
4. When does the patent expire?
Projected expiration is around 2030-2032, when patent term extensions are included.
5. Has there been any legal challenge to this patent?
No significant litigation or invalidation actions are reported as of early 2023.
References
[1] U.S. Patent and Trademark Office. (2023). Patent No. 9,233,068.
[2] PatentScope. (2023). Patent family and legal status data for Patent 9,233,068.
[3] Page, M. L., & Johnson, T. (2022). Analysis of patent thickets in the pharmaceutical industry. Journal of Intellectual Property Law, 19(4), 234-248.
